Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the ...

It is a cancer drug her company discovered—one that has made her the face of a rising pharmaceutical star. When Xia founded ...

The Bayesian Back End software (in short BayBE) represents the development of an AI-assisted experimental planner by Merck scientists across the entire group. The project has grown into an ...

German industrial giant Siemens AG said today it will pay $5.1 billion to acquire the life sciences data startup Dotmatics in an effort to expand its artificial intelligence offerings.

Merck released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data sho ...